396 related articles for article (PubMed ID: 35001356)
1. MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.
Khezri MR; Yousefi K; Zolbanin NM; Ghasemnejad-Berenji M
Mol Neurobiol; 2022 Mar; 59(3):1589-1603. PubMed ID: 35001356
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
[TBL] [Abstract][Full Text] [Related]
4. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
Tripathi R; Kumar P
Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
[TBL] [Abstract][Full Text] [Related]
6. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
7. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and Its Altered Action in Alzheimer's Disease and Parkinson's Disease.
Duc Nguyen H; Pal Yu B; Hoang NHM; Jo WH; Young Chung H; Kim MS
Neuroendocrinology; 2022; 112(5):427-445. PubMed ID: 34126620
[TBL] [Abstract][Full Text] [Related]
9. Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
Khezri MR; Ghasemnejad-Berenji M
Neurochem Res; 2022 Oct; 47(10):2954-2962. PubMed ID: 35802286
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Common Molecular Basis in Alzheimer's and Parkinson's Diseases.
Rana P; Franco EF; Rao Y; Syed K; Barh D; Azevedo V; Ramos RTJ; Ghosh P
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366155
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
12. The Olfactory Trail of Neurodegenerative Diseases.
Franco R; Garrigós C; Lillo J
Cells; 2024 Apr; 13(7):. PubMed ID: 38607054
[TBL] [Abstract][Full Text] [Related]
13. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
[TBL] [Abstract][Full Text] [Related]
14. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases.
Van der Schyf CJ
Drug Dev Res; 2016 Dec; 77(8):458-468. PubMed ID: 27813127
[TBL] [Abstract][Full Text] [Related]
16. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
[TBL] [Abstract][Full Text] [Related]
17. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
Bisht I; Ambasta RK; Kumar P
Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
[TBL] [Abstract][Full Text] [Related]
18. [Progress in lentiviral vector-mediated gene therapy for Alzheimer's disease and Parkinson's disease].
Xu D; Liu L; Lang M
Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2707-2718. PubMed ID: 33398966
[TBL] [Abstract][Full Text] [Related]
19. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
Cagin U
Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
[TBL] [Abstract][Full Text] [Related]
20. Going around in circles: deciphering the role of circular RNAs in neurodegenerative disease.
Kondo MA; Mohan A; Mather KA
Curr Opin Psychiatry; 2020 Mar; 33(2):141-147. PubMed ID: 31895158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
